Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage
Conditions: No Medicaid Coverage Sponsors: University of Wisconsin, Madison; Covering Wisconsin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage
Conditions: No Medicaid Coverage Interventions: Other: Outbound phone call Sponsors: University of Wisconsin, Madison; Covering Wisconsin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness
Conditions: Care Transitions Interventions: Behavioral: Thrive Intervention Sponsors: University of Pennsylvania; Agency for Healthcare Research and Quality (AHRQ) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Assessment of implementation methods in sepsis: study protocol for a cluster-randomized hybrid type 2 trial
This study will be entirely conducted in the Emergency Department at 18 sites. A seco ndary aim is to identify clinical sepsis phenotypes and their impact on treatment outcomes.DiscussionThis cluster-randomized trial, employing implementation science methodology, is timely and important to the field. The hybrid effectiveness-implementation design is likely to have an impact on clinical practice in sepsis management by providing a rigorous evaluation of the 1- and 3-h bundles.FundingNHLBI R01HL162954.Trial registrationClinicalTrials.gov NCT05491941. Registered on August 8, 2022. (Source: Trials)
Source: Trials - September 29, 2023 Category: Research Source Type: clinical trials
Medicare Anti-A β mAb Coverage With Evidence Development (CED) Study
Conditions: Mild Alzheimer's Disease; Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease Intervention: Drug: Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease Sponsor: Centers for Medicare and Medicaid Services/ Coverage and Analysis Group Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
Medicare Anti-A β mAb Coverage With Evidence Development (CED) Study
Conditions: Mild Alzheimer ' s Disease; Mild Cognitive Impairment (MCI) Due to Alzheimer ' s Disease Interventions: Drug: Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer ' s Disease Sponsors: Centers for Medicare and Medicaid Services/ Coverage and Analysis Group Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
Grocery Prescription Program for Medicaid Adults With Hypertension or Type 2 Diabetes
Conditions: Type 2 Diabetes Mellitus; Hypertension Intervention: Behavioral: Fresh Funds Sponsors: Alison Gustafson; Instacart Health; Kentucky Association of Health Plans Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
